[Update on the use of PET radiopharmaceuticals in inflammatory disease]

Rev Esp Med Nucl Imagen Mol. 2013 Nov-Dec;32(6):378-86. doi: 10.1016/j.remn.2013.07.003. Epub 2013 Sep 9.
[Article in Spanish]

Abstract

The use of molecular imaging with PET/CT technology using different radiotracers, especially the (18)F-FDG is currently spreading beyond the area of oncology, the most interest being placed on inflammatory and infectious diseases. This article presents a review of its contribution in different inflammatory conditions in the context of structural and conventional nuclear medicine imaging. Special emphasis is placed on the more significant diseases such as large-vessel vasculitis, sarcoidosis, rheumatoid arthritis and inflammatory bowel disease and the study of the atheroma plaque.

Keywords: (18)F-FDG PET/CT; (18)F-FDG PET/TC; Artritis reumatoide; Ateromatosis; Atheromatosis; Inflamación; Inflammation; Large vessel vasculitis; Rheumatoid arthritis; Sarcoidosis; Vasculitis de grandes vasos.

Publication types

  • Review

MeSH terms

  • Arthritis, Rheumatoid / diagnostic imaging*
  • Fluorodeoxyglucose F18*
  • Humans
  • Inflammatory Bowel Diseases / diagnosis*
  • Multimodal Imaging*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Sarcoidosis / diagnosis*
  • Tomography, X-Ray Computed*
  • Vasculitis / diagnosis*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18